Advertisement
Before you receive Nulojix (belatacept), an immunosuppressant given to people having kidney transplants, you should know that it's only for people who've been exposed to the Epstein-Barr virus (EBV), which causes mononucleosis. Past exposure to EBV lowers the risk of post-transplant lymphoproliferative disorder, or PTLD, a kind of cancer in which certain white blood cells grow out of control after a transplant. Your doctor will likely test you to be sure you have EBV antibodies before giving you Nulojix.
You should also be aware that you'll be receiving Nulojix for an extended period of time. Your doctor or a nurse will give it to you through an intravenous infusion (IV) on the day you receive a new kidney and at certain intervals thereafter. Maintenance doses are usually given monthly.
Like all drugs that suppress your immune system, you should be aware that Nulojix can raise your risk of getting sick with bacterial, viral, fungal and protozoal infections and developing other conditions, including cancer.
You should also be aware that you'll be receiving Nulojix for an extended period of time. Your doctor or a nurse will give it to you through an intravenous infusion (IV) on the day you receive a new kidney and at certain intervals thereafter. Maintenance doses are usually given monthly.
Like all drugs that suppress your immune system, you should be aware that Nulojix can raise your risk of getting sick with bacterial, viral, fungal and protozoal infections and developing other conditions, including cancer.
Continue Learning about Pharmacology
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.